Point72 Asset Management
ELVN icon

Point72 Asset Management’s Enliven Therapeutics ELVN Stock Holding History

Point72 Asset Management’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$27.1M Buy
1,353,078
+1,213,160
+867% +$24.3M 0.05% 343
2025
Q1 		$2.75M Buy
+139,918
New +$2.75M 0.01% 753
2023
Q2 		– Sell
-746
Closed -$16.3K – 1759
2023
Q1 		$16.3K Buy
+746
New +$16.3K ﹤0.01% 1465